TGFBI and cervical cancer: To date, several studies have verified LUCAT1/miR-181a axis (Zhang et al., 2019b), miR-181a-5p/TGFβI axis (Zhu et al., 2019) and miR-181a-5p/MMP14 axis (Shen et al., 2019) in cervical cancer.